Evidence map›Paper›PMID 36079094›Full record

ReviewJournal of clinical medicine2022

Does Smoking Affect OSA? What about Smoking Cessation?

Athanasia Pataka, Seraphim Kotoulas, George Kalamaras, Asterios Tzinas, Ioanna Grigoriou, Nectaria Kasnaki, Paraskevi Argyropoulou

Open access · goldAbstract readReview
In one paragraph

Review in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Athanasia PatakaRespiratory Failure Unit, G. Papanikolaou Hospital, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.ORCID 0000-0002-3252-6694
Seraphim KotoulasRespiratory Failure Unit, G. Papanikolaou Hospital, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.ORCID 0000-0002-6092-1341
George KalamarasRespiratory Failure Unit, G. Papanikolaou Hospital, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
Asterios TzinasRespiratory Failure Unit, G. Papanikolaou Hospital, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.ORCID 0000-0003-3899-5624
Ioanna GrigoriouRespiratory Failure Unit, G. Papanikolaou Hospital, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
Nectaria KasnakiRespiratory Failure Unit, G. Papanikolaou Hospital, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
Paraskevi ArgyropoulouRespiratory Failure Unit, G. Papanikolaou Hospital, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
Aristotle University of Thessaloniki · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The connection between smoking and Obstructive sleep apnea (OSA) is not yet clear. There are studies that have confirmed the effect of smoking on sleep disordered breathing, whereas others did not. Nicotine affects sleep, as smokers have prolonged total sleep and REM latency, reduced sleep efficiency, total sleep time, and slow wave sleep. Smoking cessation has been related with impaired sleep. The health consequences of cigarette smoking are well documented, but the effect of smoking cessation on OSA has not been extensively studied. Smoking cessation should improve OSA as upper airway oedema may reduce, but there is limited data to support this hypothesis. The impact of smoking cessation pharmacotherapy on OSA has been studied, especially for nicotine replacement therapy (NRT). However, there are limited data on other smoking cessation medications as bupropion, varenicline, nortriptyline, clonidine, and cytisine. The aim of this review was to explore the current evidence on the association between smoking and OSA, to evaluate if smoking cessation affects OSA, and to investigate the possible effects of different pharmacologic strategies offered for smoking cessation on OSA.

Indexed as

bupropionclonidinecytisinenicotine replacement therapynortriptylineobstructive sleep apneasmokingsmoking cessationtreatmentvarenicline

Identifiers

PMID36079094
PMCPMC9457519
OpenAlexW4294307531

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.